Queen’s University Belfast (QUB) is taking part in a UK-wide trial to investigate whether a drug normally used to treat high blood pressure could also slow down the progression of Alzheimer’s Disease (AD).
Members of PIER (Public Involvement Enhancing Research) and NICRCF (The NI Cancer Research consumer Forum) attended a workshop led by Professor Alistair Fee.
ABPI LINC (Library of Initiatives for Novel Collaborations) allows academic researchers to search for open opportunities for collaboration with the biopharmaceutical industry.
